Article
In the best of all worlds, ophthalmologists, whether in solo or group practice, would be able to solve practice problems before they became big enough to have an effect on overall performance. However, experience tells us otherwise.
Stuart Therapeutics completes Phase 3 trial of vezocolmitide for treatment of dry eye disease
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
BLINK2 study confirms lasting myopia control benefits in teenagers
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
HelpMeSee announces new training partnerships, simulation training sites
Glaukos announces several positive clinical updates for its iDose platform